Tag: center

The European data center colocation market is rapidly expanding, valued at $56.72 billion in 2024 and projected to reach $226.76 billion by 2034 with a CAGR of 13.68%. This growth is driven by rising cloud adoption, the need for scalable IT infrastructure, and stringent data protection laws like GDPR. As businesses transition to hybrid IT models, colocation services offer secure, cost-effective solutions that eliminate the need for costly on-premise infrastructure. The market also benefits from trends in edge computing, sustainability, and green energy adoption. Key markets include Frankfurt, Amsterdam, Paris, and London, with expansion in Southern and Eastern Europe.

The acquisition by Heimar hf. ("Heimar" or the "Company") of all shares in Gróska ehf. (“Gróska”) and Gróðurhúsið ehf. (“Gróðurhúsið”) (the “Transaction”), which was initially announced on 23 April this year, has now been completed. 

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announces that dosing has commenced at the prestigious Weill Cornell Medicine Multiple Sclerosis Center in New York City, in its ongoing Phase 2 clinical trial evaluating intranasal foralumab in patients with non-active Secondary Progressive Multiple Sclerosis (na-SPMS). This fifth site complements existing sites at Yale University, Johns Hopkins University, Brigham and Women's Hospital, and the University of Massachusetts.

New clinical results show sustained CRi, deep bone marrow responses, and encouraging survival in FLT3-mutant AML patients, including those previously treated with gilteritinib